Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONMED Corp
Report date March 01, 2018 · Filed March 05, 2018
Section 16 reporting ended · disclosed 2018-03-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-03-02 transaction · row 9
9 source rows · reconciled sequenceRow 1 · 2018-03-01 · Exercise / conversion · Acquired 600 · Balance 600 Row 2 · 2018-03-01 · Tax withholding · Disposed 252 · Balance 348 Row 3 · 2018-03-01 · Exercise / conversion · Acquired 650 · Balance 998 Row 4 · 2018-03-01 · Tax withholding · Disposed 273 · Balance 725 Row 5 · 2018-03-01 · Exercise / conversion · Acquired 10,020 · Balance 10,745 Row 6 · 2018-03-01 · Sale · Disposed 10,020 · Balance 725 F1: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Row 7 · 2018-03-01 · Exercise / conversion · Acquired 9,600 · Balance 10,325 Row 8 · 2018-03-01 · Sale · Disposed 9,600 · Balance 725 F1: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Row 9 · 2018-03-02 · Sale · Disposed 725 · Balance 0 |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2025-02-27 | Direct | 600 |
Reported balance
After 2018-03-01 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-03-01 · Exercise / conversion · Disposed 600 · Balance 600 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-03-01 | Direct | 1,300 |
Reported balance
After 2018-03-01 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2018-03-01 · Exercise / conversion · Disposed 650 · Balance 1,300 F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $39.87 · Expires 2026-03-01 | Direct | 30,060 |
Reported balance
After 2018-03-01 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2018-03-01 · Exercise / conversion · Disposed 10,020 · Balance 30,060 F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
| Options To Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $41.93 · Expires 2027-03-01 | Direct | 38,400 |
Reported balance
After 2018-03-01 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2018-03-01 · Exercise / conversion · Disposed 9,600 · Balance 38,400 F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period |
Filing footnotes · ownership attribution and instrument terms
F1: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 725 | $60.00 | $43,500.00 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 9 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 9,600 | $0.00 Strike: $41.93 | $0.00 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · derivative · entry 13 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,400 Underlying: Common Stock · 9,600 shares Expires 2027-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 10,020 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · derivative · entry 12 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,060 Underlying: Common Stock · 10,020 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · derivative · entry 11 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 650 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · derivative · entry 10 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Common Stock · 600 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 9,600 | $60.19 | $577,810.56 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 8 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725 F1 · price: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 9,600 | $41.93 | $402,528.00 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 7 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,325 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 10,020 | $60.20 | $603,162.92 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 6 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725 F1 · price: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 10,020 | $39.87 | $399,497.40 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 5 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,745 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 273 | $59.96 | $16,369.08 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 4 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 3 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 252 | $59.96 | $15,109.92 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 2 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348 Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 22:20 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010168 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2018 Filed Feb 13, 2018 21:54 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,962 | $60.25 | $118,210.50 |
DisclosureSEC source: 0001127602-18-005546 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 19:01 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 18,400 | $0.00 Strike: $51.30 | $0.00 |
DisclosureSEC source: 0001127602-18-003917 · form4.xml · derivative · entry 4 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,600 Underlying: Common Stock · 18,400 shares Expires 2025-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 19:01 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 16,438 | $63.35 | $1,041,347.30 |
DisclosureSEC source: 0001127602-18-003917 · form4.xml · nonDerivative · entry 3 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,962 Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 19:01 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 18,400 | $51.30 | $943,920.00 |
DisclosureSEC source: 0001127602-18-003917 · form4.xml · nonDerivative · entry 2 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2018 Filed Feb 5, 2018 19:01 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 18,023 | $63.38 | $1,142,229.25 |
DisclosureSEC source: 0001127602-18-003917 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · Advisor to CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.88. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 09, 2017 Filed Nov 9, 2017 21:18 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 4,000 | $50.70 | $202,800.00 |
DisclosureSEC source: 0001127602-17-031737 · form4.xml · nonDerivative · entry 4 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,023 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.65 to $50.75. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 08, 2017 Filed Nov 9, 2017 21:18 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 12,934 | $50.77 | $656,659.18 |
DisclosureSEC source: 0001127602-17-031737 · form4.xml · nonDerivative · entry 3 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,023 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.54 to $51.14. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:18 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 10,529 | $50.60 | $532,767.40 |
DisclosureSEC source: 0001127602-17-031737 · form4.xml · nonDerivative · entry 2 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,957 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.50 to $50.72. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:18 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 1,900 | $50.82 | $96,558.00 |
DisclosureSEC source: 0001127602-17-031737 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,486 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.59 to $50.99. Full information regarding the number of shares sold at each separate price will be provided upon the request of the commission staff, ConMed, or a ConMed security holder. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 4,680 | $0.00 Strike: $44.90 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 21 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,120 Underlying: Common Stock · 4,680 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 9,600 | $0.00 Strike: $32.93 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 20 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,400 Underlying: Common Stock · 9,600 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 10,000 | $0.00 Strike: $26.09 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 19 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 10,000 | $0.00 Strike: $27.63 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 18 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 10,000 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 17 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2020-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionSars (Stock Appreciation Rights) · Derivative | 8,000 | $0.00 Strike: $16.46 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 16 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2019-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionOptions To Purchase Common Stock · Derivative | 10,020 | $0.00 Strike: $39.87 | $0.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · derivative · entry 15 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,080 Underlying: Common Stock · 10,020 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 4,315 | $53.37 | $230,291.55 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 14 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,386 Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 4,680 | $44.90 | $210,132.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 13 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 7,790 | $53.37 | $415,752.30 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 12 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,021 Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 9,600 | $32.93 | $316,128.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 11 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,811 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 7,484 | $53.37 | $399,421.08 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 10 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,211 Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 10,000 | $26.09 | $260,900.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 9 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,695 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 7,626 | $53.37 | $406,999.62 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 8 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,695 Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 10,000 | $27.63 | $276,300.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 7 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 6,854 | $53.37 | $365,797.98 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 6 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,321 Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 10,000 | $19.26 | $192,600.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 5 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 5,277 | $53.37 | $281,633.49 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 4 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,175 Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 8,000 | $16.46 | $131,680.00 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 3 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | SaleCommon Stock | 10,020 | $53.57 | $536,771.40 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 2 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,452 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.55 to $53.595. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder." Read SEC document |
| November 03, 2017 Filed Nov 7, 2017 17:32 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 10,020 | $39.87 | $399,497.40 |
DisclosureSEC source: 0001127602-17-031437 · form4.xml · nonDerivative · entry 1 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 650 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · derivative · entry 12 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,300 Underlying: Common Stock · 650 shares Expires 2024-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · derivative · entry 11 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2023-07-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs vesting over a five year period with the first 20% of the RSU's vesting June 1, 2014. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 1,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · derivative · entry 10 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2023-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 800 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · derivative · entry 9 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 800 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 241 | $51.90 | $12,507.90 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · nonDerivative · entry 8 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,452 Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · nonDerivative · entry 7 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,693 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2017 Filed Jun 2, 2017 16:13 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 370 | $51.90 | $19,203.00 |
DisclosureSEC source: 0001127602-17-020202 · form4.xml · nonDerivative · entry 6 POMILIO LUKE A · CIK 0001238337 · EVP, Finance & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,043 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.